Sign In
Create Account
Forgot Password?
Google Play
App Store
Save
Featured
Webinars
Events
eLearning & CME
Topics
Industry portal
Journals
Open access
Search
Loading
Navbar input
WAIT FOR SUGGESTIONS BY CATEGORY
OR CONTINUE TYPING IN YOUR KEYWORDS
ENTER ONE OR MULTIPLE KEYWORDS &
PRESS THE SEARCH BUTTON
From
To
Search
Favorites
Advanced
Minimize
More ▾
Less ▸
Clear
Protected by US Patents
For full functionality of this site it is necessary to enable JavaScript. Here are the
instructions how to enable JavaScript in your web browser
.
PB1109 Development and Evaluation of an Aptamer-Based Affinity Purification Method for Activated Protein C (APC)
ISTH Academy, Faculty / Presenters, 406821
PB1110 Implementation of International Society on Thrombosis and Haemostasis Definitions of Major and Clinically Relevant Non-Major Bleed Events in Electronic Health Records
ISTH Academy, Faculty / Presenters, 406822
PB1111 Lupus Anticoagulant Diagnosis: Real Life Rate of Interferences Due to Anticoagulant Treatment in a Laboratory of a High Complexity Hospital
ISTH Academy, Faculty / Presenters, 406823
PB1112 UK National External Quality Assessment Scheme for Blood Coagulation (UK NEQAS BC) Emicizumab Programme, Survey July 2022 Results for Modified One-Stage Assay and Chromogenic Assay
ISTH Academy, Faculty / Presenters, 406824
PB1103 Clinical Performance Evaluation of the New Stago Systems for APTT Determination: sthemO PTTA and sthemO CK Prest on sthemO 301 Analyzer
ISTH Academy, Faculty / Presenters, 406825
PB1104 Evaluation of Abnormal Routine Coagulation Results (PT and APTT) for Specialist Review in a Tertiary Teaching Hospital
ISTH Academy, Faculty / Presenters, 406826
PB1105 Post-Infusion Monitoring of Afstyla FVIII Replacement Therapy - Data from the UK National External Quality Assessment for Blood Coagulation (UK NEQAS BC) Programme 2022
ISTH Academy, Faculty / Presenters, 406827
PB1205 In Vitro Analysis of Plasma Clots with 0.7 to 10.4 g/L Fibrinogen Concentration by Turbidity, Permeation and Laser Scanning Electron Microscopy
ISTH Academy, Faculty / Presenters, 406828
PB1204 Synergistic Role in Accelerating Clot Formation and Fibrin Polymerisation of Cancer Cells and Platelets: a Thromboelastometric Study
ISTH Academy, Faculty / Presenters, 406829
PB1202 Fibrinogen Concentration and Plasma Clot Properties as Predictors of Cardiovascular Disease Mortality in Black South Africans
ISTH Academy, Faculty / Presenters, 406830
PB1203 The Influence of Human Immunodeficiency Virus Infection and Antiretroviral Therapy on Plasma Clot Properties in a Group of Black South African Women
ISTH Academy, Faculty / Presenters, 406831
PB1201 Update on the Proposed Standardized Method for Scanning Electron Microscopy Analysis of Fibrin Clots
ISTH Academy, Faculty / Presenters, 406832
PB1200 Evaluation of the Association of Factor XIII at Hospital Arrival and Outcomes in a Cohort of Severely Injured Patients
ISTH Academy, Faculty / Presenters, 406833
PB1195 Biochemical and Structural Regulation of the Enzymatic Degradation of Blood Clots
ISTH Academy, Faculty / Presenters, 406834
PB1196 In Vitro Comparisons of Two Fibrinogen Concentrates on Fibrin Clot Properties in Dysfibrinogenemia
ISTH Academy, Faculty / Presenters, 406835
PB1197 Neutrophil Serine Proteases Cleave Fibrinogen to Alter Fibrin Clot Structure
ISTH Academy, Faculty / Presenters, 406836
PB1193 Acute Myocardial Infarction Thrombi Show Fibrin Film that Increases with Ischaemia Duration
ISTH Academy, Faculty / Presenters, 406837
PB1198 Retrospective Genotypic Data Analysis of Patients with Suspected Hereditary Fibrinogen Deficiency
ISTH Academy, Faculty / Presenters, 406838
PB1214 Characterization of Dynamic Changes to Fibrinolysis in Porcine Model of Cardiac Arrest
ISTH Academy, Faculty / Presenters, 406839
PB1212 Effect of PAI-1 on Clot Structure and Fibrinolysis
ISTH Academy, Faculty / Presenters, 406840
PB1213 The Development of a Mini-Scale Euglobulin Clot Lysis Assay
ISTH Academy, Faculty / Presenters, 406841
PB1210 Incorporation of a2-Plasmin Inhibitor into Plasma Clots of Patients with Venous Thrombosis
ISTH Academy, Faculty / Presenters, 406842
PB1211 Individual Determination of the Components of the Fibrinolytic System in Platelet-Depleted Plasma and Derived Euglobulin Fraction
ISTH Academy, Faculty / Presenters, 406843
PB1209 Thrombo-Inflammatory and Fibrinolytic Deficit Biomarkers and their Relationship with Circulating Glycosaminoglycans in End-Stage Renal Disease Patients
ISTH Academy, Faculty / Presenters, 406844
PB1208 Thrombin Activatable Fibrinolysis Inhibitor Dependent Effects on Whole Blood Clot Formation and Lysis Dynamics Across the Peripartum Period
ISTH Academy, Faculty / Presenters, 406845
PB1206 Plasmin Generation is Impaired in Patients with Bleeding Disorders of Unknown Cause
ISTH Academy, Faculty / Presenters, 406846
PB1217 The Contribution of Plasmin(ogen) Receptors to Neuroinflammation in a Murine Model of MS
ISTH Academy, Faculty / Presenters, 406847
PB1224 Cell-Lysis (Lysozyme) Activity in Japanese Fermented Food-Natto
ISTH Academy, Faculty / Presenters, 406848
PB1220 DNase-1 Overcomes Thrombolytic rT-PA Resistance of Platelet-Rich Ischemic Stroke Thrombi
ISTH Academy, Faculty / Presenters, 406849
PB1223 EkoSonic Endovascular System Promotes Thrombolysis by Altering Fibrin Fibre Thickness
ISTH Academy, Faculty / Presenters, 406850
PB1221 Prospective Study Comparing Point-of-Care Viscoelastic Testing and Standard Laboratory Testing for the Prediction of Bleeding Complications in Patients after Systemic Thrombolysis Therapy
ISTH Academy, Faculty / Presenters, 406851
PB1222 ROTEM-Identified Hyperfibrinolysis does not Correlate with Poor Outcomes in Large Vessel Occlusion Stroke
ISTH Academy, Faculty / Presenters, 406852
PB1219 Structure-Function Studies on the Serine Protease Domain of Factor VII Activating Protease (FSAP) to Characterize its Interaction with Substrates and Inhibitors
ISTH Academy, Faculty / Presenters, 406853
PB1218 Aptamer Inhibitor of Von Willebrand Factor Induces Thrombolysis and Improves Vascular Patency Upon Immediate and Delayed Treatment in a Microfluidic Model of Stroke
ISTH Academy, Faculty / Presenters, 406854
PB1233 A Single-Center Study of Reduced-Dose Corticosteroids Therapy for Patients with Acquired Hemophilia A
ISTH Academy, Faculty / Presenters, 406855
PB1235 Acquired Hemophilia A in Very Old Patients: Issues on Therapy Choice. A Case Report
ISTH Academy, Faculty / Presenters, 406856
PB1234 Prevalence of Studies with Acquired von Willebrand Syndrome Laboratory Profile at the Hospital Italiano de Buenos Aires (HIBA)
ISTH Academy, Faculty / Presenters, 406857
PB1229 Haemostatic Control with Recombinant Porcine Factor VIII in Acquired Haemophilia A
ISTH Academy, Faculty / Presenters, 406858
PB1230 Single Centre Review of Practice for Treatment of Acquired Haemophilia A Patients
ISTH Academy, Faculty / Presenters, 406859
PB1228 Inhibitor Detection in Acquired Hemophilia A: A Comparison between the Nijmegen Modified Bethesda Assay and an Anti-FVIII ELISA
ISTH Academy, Faculty / Presenters, 406860
PB1227 Lupus Anticoagulant in Acquired Hemophilia A Subjects in Quebec: Data from the Quebec Reference Center for Inhibitors
ISTH Academy, Faculty / Presenters, 406861
PB1226 Acquired Haemophilia A in Finland: A Nationwide Study of Incidence, Treatment and Outcomes
ISTH Academy, Faculty / Presenters, 406862
PB1225 Acquired Haemophilia in the COVID-19 Pandemic Era - Does Vaccination or Infection Increase its Risk and Influence Outcomes?
ISTH Academy, Faculty / Presenters, 406863
PB0617 Kinetics of Clot Formation and Fibrinolysis in Severely Injured Trauma Patients
ISTH Academy, Faculty / Presenters, 406864
PB0616 UK National External Quality Assessment Scheme for Blood Coagulation (UK NEQAS BC) Evaluation of the Point of Care Fibrinogen Device
ISTH Academy, Faculty / Presenters, 406865
PB0614 Use of a Microfluidic Model to Evaluate Platelet Function in Traumatic Brain Injury Patients Pre- and Post- Platelet Transfusion
ISTH Academy, Faculty / Presenters, 406866
PB0177 An Examination of Access to Preventive Therapies for Persons with Hemophilia (PWH): A Pilot Survey on Behalf of the International Prophylaxis Study Group (IPSG)
ISTH Academy, Faculty / Presenters, 406867
PB0178 Factor X Enhances the Coagulant Potentials of Emicizumab
ISTH Academy, Faculty / Presenters, 406868
PB0174 Half-Life of Factor VIII in an Adult and Pediatric Population: Study at 03 Centers in Western Algeria
ISTH Academy, Faculty / Presenters, 406869
PB0175 Impact of Reagent on the Estimation of Eloctate and Adynovate Pharmacokinetic (PK) Parameters?
ISTH Academy, Faculty / Presenters, 406870
PB0176 Laboratory Monitoring of Severe Hemophilia Patients during PK at the Hemowab Reference Center: A Retrospective Study
ISTH Academy, Faculty / Presenters, 406871
PB0170 Evaluation of the Extended-Half Life FVIII Products' Measurement Accuracy and Precision With Five Different Types of Laboratory Assays
ISTH Academy, Faculty / Presenters, 406872
PB0173 Coagulation Assay Discrepancies for Factor IX Activity in Hemophilia B
ISTH Academy, Faculty / Presenters, 406873
PB0171 Polymorphisms in MAPk9 and CSF1R Associated with Immune Regulatory Gene and their Impact on Inhibitor Development in Patients with Hemophilia A
ISTH Academy, Faculty / Presenters, 406874
PB0172 Thrombodynamics: A Novel Assay for Diagnostic Evaluation of Haemophilia A Patients
ISTH Academy, Faculty / Presenters, 406875
PB0167 De Novo Intron 22 Inversion Carrier Detection - The Emerging Value of Genetic Analysis in a Devloping Country
ISTH Academy, Faculty / Presenters, 406876
PB0168 In Vitro Assessment of Clinical Coagulation Assays in the Presence of Concizumab
ISTH Academy, Faculty / Presenters, 406877
PB0169 Unearthing the Genotype-Inhibitor Phenotype Association in Severe Hemophilia A: A North Indian Cohort Study
ISTH Academy, Faculty / Presenters, 406878
PB0166 Liver Directed Gene Therapy in Hemophilia A Mice is Dependent on Notch Pathway Driven Endothelial Development
ISTH Academy, Faculty / Presenters, 406879
PB0163 Differential Binding of Recombinant FVIII Products to Platelets, and Impact of FVIII on VWF Expression and Platelet Contractility In Vitro
ISTH Academy, Faculty / Presenters, 406880
PB0164 Full Characterization of Three F8 Deletions Causing Severe Hemophilia A with High Responding FVIII Inhibitors may be Associated with the Mechanism of Microhomology-Mediated Break-Induced Replication
ISTH Academy, Faculty / Presenters, 406881
PB0165 Gene Correction of Human Hemophilia B Mutation by PAM-Flexible Cas9-Mediated Base-Editing Approach
ISTH Academy, Faculty / Presenters, 406882
PB0157 In Vitro Thrombin Generation in the Presence of Emicizumab Sequence Identical Analogue (emi-SIA) and Concizumab
ISTH Academy, Faculty / Presenters, 406883
PB0158 Preanalytical Quenching of FVIII Using FVIII-Inhibitors Improves the Specificity of Functional Emicizumab Testing
ISTH Academy, Faculty / Presenters, 406884
PB0159 Relative Role of Auxiliary Plasma Protease Inhibitors in Thrombin Inhibition at Reduced Antithrombin Levels
ISTH Academy, Faculty / Presenters, 406885
PB0160 The Impact of Past Inhibitor on Health Status in Patients with Haemophilia a in The Netherlands
ISTH Academy, Faculty / Presenters, 406886
PB0161 The Potential Role of Matrix Metalloproteinases in the Onset of Haemophilic Arthropathy
ISTH Academy, Faculty / Presenters, 406887
PB0154 Blood-Induced Inflammation in Hemophilia is Associated with Impaired Macrophage Function
ISTH Academy, Faculty / Presenters, 406888
PB0155 Characterization of Zebrafish F8 Mutant and Modeling Hemophilia A
ISTH Academy, Faculty / Presenters, 406889
PB0156 Higher Thrombin Generation is Predicted when Switching Directly from Emicizumab to Mim8 in Patients with Hemophilia A
ISTH Academy, Faculty / Presenters, 406890
PB0153 Evaluation of Cell Type-Specificity of Native Enhancer Elements from the F8 Locus
ISTH Academy, Faculty / Presenters, 406891
PB0150 Fibrin Clot Formation is a Reliable Biological Marker to Evaluate FVIII Replacement Therapy in Hemophilia A Patients
ISTH Academy, Faculty / Presenters, 406892
PB0151 The Effect of Single and Combined Knockouts of GABARAPs Proteins Family on FVIII Intracellular Localization and Secretion
ISTH Academy, Faculty / Presenters, 406893
PB0152 The Spectrum of FVIII-Specific Antibodies in Persons with Hemophilia A: A Cross-Sectional Nationwide Population Study
ISTH Academy, Faculty / Presenters, 406894
PB0145 Extra-Hemostatic Roles of FVIII in Musculoskeletal System in a FVIII Knockout Mice Model
ISTH Academy, Faculty / Presenters, 406895
PB0146 Functional Characterization of a Human F9 Gene-Inserted Product in Hemophilia B Mice
ISTH Academy, Faculty / Presenters, 406896
PB0147 FVIII/Anti-FVIII Immune Complexes Prevent FVIII-Specific Activation of B Cells in a Hemophilia A Mouse Model
ISTH Academy, Faculty / Presenters, 406897
PB0143 Induced B Cell Tolerance in Hemophilia A Mice is Destroyed by Infections
ISTH Academy, Faculty / Presenters, 406898
PB0142 FVIII-Containing Immune Complexes Interrupt Platelet Aggregation in an Ex-Vivo Model of Primary Hemostasis
ISTH Academy, Faculty / Presenters, 406899
PB1303 A Study of Support for Hemophilia Patients Using the “ Questionnaire for Daily Movement and Sensory of PwH”
ISTH Academy, Faculty / Presenters, 406900
PB1304 Development of a Multidisciplinary Bleeding Disorder Committee in a Reference Hospital
ISTH Academy, Faculty / Presenters, 406901
PB1306 Inhibitor Recurrence Following Immune Tolerance Induction in a Hemophilia A Patient with Inhibitor Post COVID-19 Infection
ISTH Academy, Faculty / Presenters, 406902
PB1307 Management of Severe Hemophilia A Patients: Low-Dose Prophylaxis vs On- Demand Treatment
ISTH Academy, Faculty / Presenters, 406903
PB1308 Successful Hip Arthroplasty in a Patient with Combined Factor V and Factor FVIII Deficiency
ISTH Academy, Faculty / Presenters, 406904
PB1309 Switching from Factor VIIa to Emicizumab in Patients with Hemophilia A and Inhibitor (HAI) in Korea
ISTH Academy, Faculty / Presenters, 406905
PB1300 Intramural Hematoma of Gastrointestinal Tract in People With Hemophilia: A Pooled Study
ISTH Academy, Faculty / Presenters, 406906
PB1301 Low-Titer Inhibitor and Decreased FVIII Activity to 1.1% with Increased Bleeding in a 4 Year Old Patient with Congenital Mild Hemophilia A
ISTH Academy, Faculty / Presenters, 406907
PB1297 A UK Single Centre Experience of Switching Adolescents with Severe Haemophilia A to Turoctocog Alfa Pegol
ISTH Academy, Faculty / Presenters, 406908
PB1299 Obstetrical Decision-Making in Moderate or Severe Hemophilia A and B: A Qualitative Study Exploring Parents' Experiences, Preferences and Needs
ISTH Academy, Faculty / Presenters, 406909
PB1294 First Reported Case of Cardiac Surgery in A Patient with Hemophilia B on Treatment with Albutrepenonacog Alfa (rIX-FP)
ISTH Academy, Faculty / Presenters, 406910
PB1296 A Prospective, Non-Interventional Study to Investigate the Effectiveness of rVIII-SingleChain in Patients with Hemophilia A
ISTH Academy, Faculty / Presenters, 406911
PB1291 Joint Range of Motion Findings Among Female Patients with Hemophilia A from the ATHNdataset
ISTH Academy, Faculty / Presenters, 406912
PB1292 Rationale and Design of PathfinderReal: A Prospective, Non- Interventional Study Assessing Joint Health in Adults With Haemophilia A after Switching to Prophylaxis with Turoctocog Alpha Pegol (N8-GP)
ISTH Academy, Faculty / Presenters, 406913
PB1285 A Novel Mutation of Haemophilia C in a Kindred: a F11 Splice Site Variant
ISTH Academy, Faculty / Presenters, 406914
PB1286 Cardiac Surgery in a Patient with Severe Haemophilia A Receiving Emicizumab Prophylaxis - A Case Report
ISTH Academy, Faculty / Presenters, 406915
PB1287 Efficacy of Florio Haemo in Improving Health-Related Quality of Life and Treatment Adherence in Patients with Hemophilia
ISTH Academy, Faculty / Presenters, 406916
PB1288 Immune Tolerance Induction (ITI) Strategies in Haemophilia A Patients with Inhibitors - Data from the MOTIVATE Study
ISTH Academy, Faculty / Presenters, 406917
PB1289 Real-World Data of Hemophilia A with Inhibitor Patients Using Emicizumab - 1st Report in Korea
ISTH Academy, Faculty / Presenters, 406918
PB1290 Successful Very Low Dose Immune Tolerance Induction with Albutrepenonacog Alfa in a Severe Hemophilia B Child with Anaphylactic Reaction to Factor IX
ISTH Academy, Faculty / Presenters, 406919
PB1279 E- Health Applications on Hemophilia Patients: Review and Experience in a Reference Hospital in Spain
ISTH Academy, Faculty / Presenters, 406920
«
...
14
15
16
17
18
19
20
21
22
...
»